Bioalpha signs MoU with Zuellig Pharma for vaccine distribution

KUALA LUMPUR: Bioalpha Holdings Bhd's subsidiary has entered a memorandum of understanding with Zuellig Pharma Sdn Bhd for the import and distribution of the Covid-19 vaccine in Malaysia.

It said in a filing with Bursa Malaysia that the contract shall be effective from Jan 22, 2021 and is subject to approval from the relevant authorities for the distirubtion and sale of the vaccine.

"The MOU enables the Company to expand its business into distribution of vaccines, such as Covid-19 vaccine, which has favourable prospects following the recent pandemic," said Bioalpha.
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Bioalpha , Zuellig Pharma , vaccine


Did you find this article insightful?


100% readers found this article insightful

Next In Business News

UEM Edgenta to save RM100mil in shift towards healthcare tech solutions
AmInvest Research lowers end-2021 KLCI target to 1,695
UOB Kay Hian Research keeps buy call on Top Glove, lower TP RM7.60
AMMB posts net profit of RM262.8m in 3Q, RM1.09b in 9M
John Holland Gamuda JV shortlisted for airport metro
Lim Hock San appointed executive chairman of LBS Bina Group
KAB resolves dispute with ICEE International
KLCI back in the red, gloves extend declines
Invest Energy plans RM2.2b investment with European ESG fund
Malaysia's manufacturing PMI falls in February

Stories You'll Enjoy